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Abstract  
Many of the >2 million animal species that inhabit earth have developed survival mechanisms 
that aid in the prevention of obesity, kidney disease, starvation, dehydration and vascular 
ageing; however, some animals remain susceptible to these complications. Domestic and 
captive felids, for example, show susceptibility to chronic kidney disease (CKD), potentially 
linked to the high protein intake of these animals. By contrast, naked mole rats are a model of 
longevity and are protected from extreme environmental conditions through mechanisms that 
provide resistance to oxidative stress. Biomimetic studies suggest that the transcription factor 
NRF2 may offer protection in extreme environmental conditions and promote longevity in the 
animal kingdom. Similarly, during months of fasting, immobilization and anuria, hibernating 
bears are protected from muscle wasting, azotaemia, thrombotic complications, organ damage 
and osteoporosis — features that are often associated with CKD. Improved understanding of 
susceptibility and protective mechanisms of these animals and others could provide insights 
into novel strategies to prevent and treat several human diseases, such as CKD and ageing-
associated complications. An integrated collaboration between nephrologists and experts from 
other fields, such as veterinarians, zoologists, biologists, anthropologists and ecologists, could 
introduce a novel approach for improving human health and help nephrologists to find novel 
treatment strategies for CKD. 
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The evolution of species — mediated by genetic and epigenetic modifications over the past 3.8 
billion years — has given rise to a wide variety of adaptations to different environments. This 
observation has led to the proposal that insights into adaptive mechanisms observed in nature 
could aid the development of therapeutic approaches for human disease (1). Comparative 
physiology — a subdiscipline of physiology that is based on Krogh’s principle, which states ”for 
such a large number of problems there will be some animal of choice, or a few such animals, on 
which it can be conveniently studied” — involves the comparison of organ systems within 
different taxa (2). Homer Smith’s insightful work, for example, used a comparative physiology 
approach based on studies of fish and amphibians (3) to form the basis of many aspects of renal 
physiology. Similarly, Ivan Sperber (4) studied correlations between dietary habits, ecological 
distribution, urine-concentrating ability and kidney morphology in 1944. The emerging field of 
biomimetics explores adaptative mechanisms of a given species and imitates — or takes 
inspiration from — these mechanisms to solve human problems (Table 1; Supplementary 
information S1 (table)). Biomimetics is a particularly interdisciplinary field that can be used to 
identify new approaches to disease (Figure 1), such as the underlying mechanisms of longevity 
in naked mole rats (5), resistance to long-term renal hypoxia in seals (6) and preserved renal 
function in hibernating bears (7, 8). However, it is important to emphasize that when 
interpreting data from biomimetic studies, one should consider the likelihood of comparative 
animal data offering meaningful solutions when extrapolated to human disease. The 
physiological mechanisms that have evolved to enable healthy animals to adapt to extreme 
environments may not necessarily be the same mechanisms that should be harnessed to avoid 
disease in humans.  
The prevalence of chronic kidney disease (CKD) is rising worldwide. Approximately 10–
15% of the global population suffer from CKD and its associated complications (9), particularly 
cardiovascular disease, infectious complications, osteoporosis, muscle wasting, frailty and 
premature ageing (10) (11). Nephrologists are faced with limited treatment options for patients 
with CKD, and advances in dialysis technology have not yet translated into markedly better 
outcomes (10). As the majority of randomized controlled trials for CKD therapies have been 
negative (10), an urgent need exists to find novel treatment options for this patient group. 
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Here, we discuss some examples of renal biomimetics, and how studies of the mechanisms by 
which animals adapt to hypoxia, oxidative stress, food deprivation and conversely to high-
protein, or high-phosphate diets, may result in a better understanding of the uraemic 
phenotype (Figure 1). Although biomimetic studies usually focus on the adaptive mechanisms 
that protect species from disease, changing environments — such as global warming, water 
availability or salinity in the oceans — can also lead to adaptations that may not offer full 
protection from these changes but may still shed light on disease mechanisms. Examples 
include the study of mechanisms that lead to the extinction of a species and the inability of that 
species to adapt to a changing environment.  
[H1] High-protein diets and dehydration  
High-protein diets that are rich in red meat accelerate the progression of both experimental 
and human CKD (12, 13). The link between a high-protein diet and CKD (Figure 2) suggests that 
one might obtain mechanistic insights from studying mammals that live almost exclusively on a 
high-protein diet, such as the Felidae family (felids) and Desmodontinae (vampire bats). 
Interestingly, one group (felids) seems to be susceptible to CKD, while the other (vampire bats) 
seems to be protected.  
 
[H2] CKD in felids. Felids consist of 37 species in the wild. Although they are considered among 
the world’s most successful carnivore families, they are particularly susceptible to kidney 
diseases, including polycystic kidney disease (14), glomerulonephritis (15), acute pyelonephritis, 
hypertension-associated CKD (16) and nephrolithiasis (17). The most common kidney pathology 
in domestic felids is chronic tubulointerstitial fibrosis, which is sometimes observed with 
glomerulosclerosis (14). The prevalence of CKD in domestic cats has increased 75-fold (from 
0.04% to 3%) during the last four decades, although this increase might be partially due to 
improved diagnostics (18, 19) (22) and also due to increased nonsteroidal anti-inflammatory 
drug (NSAID) consumption in the last decade (20). Even so, CKD is thought to affect 35–80% of 
geriatric domestic cats and is the most common cause of death in domestic cats >5 years of age 
(19). Likewise, a necropsy study found renal lesions in 87% of big felids (mainly tigers, leopards 
and lions) held at zoos and safari parks in Germany (21). In the wild, free-ranging felids 
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experience a range of kidney diseases of differing origins, such as viral infections or amyloid 
deposition; however, free-ranging animals typically die from other causes before renal disese 
manifests or only show a mild form of disease (22). Extrinsic environmental or dietary factors 
that might promote the development of kidney disease among felids in captivity, seem to be 
absent among wild felids (22).   
 As mentioned above, the most common renal pathology among captive and domestic 
felids is chronic tubulointerstitial fibrosis, which is associated with minimal or mild proteinuria, 
normal blood pressure, hypokalaemia, hypo- or hypernatraemia, polydipsia and polyuria (18, 
23) and an absence of diabetes mellitus (24). Hypertension, if present, is usually thought to be 
secondary to the renal disease (18). Microvascular lesions observed in chronic hypertensive 
renal injury are absent or only minimally present (25). The cause of this type of CKD remains 
unknown; however, it is unlikely that felids have evolved a selective susceptiblity to CKD. 
Hence, one might hypothesize that the dramatic increase in felid CKD might reflect a new 
environmental exposure to which felids are particularly susceptible. Insights into the underlying 
mechanisms might be gained from comparisons with populations of humans and other animals 
that are either affected by or protected from renal disease, as discussed in further detail below. 
As CKD among felids has been best described in domestic cats and felids in wildlife parks, one 
possibility is that this disease might reflect the contamination of meat with a nephrotoxic 
substance. This scenario is similar to the epidemic of renal disease that occurred in vultures in 
India and Pakistan, which was ascribed to the practice of treating cattle with NSAIDs that 
contaminated the cattle meat (26) .  
 
[H3] The effect of red meat intake. Another potential mechanism of the high prevalence of CKD 
in felids might relate to their high intake of red meat (Figure 2). To meet the high energy 
demands of their brain, which is relatively large in comparison with body size (27), greater 
quantities of proteins are required, predominantly to generate glucose from amino acids 
through de novo gluconeogenesis. High-protein diets induce vasodilation of afferent renal 
arterioles, glomerular hypertension and hyperfiltration, which together accelerate the 
progression of pre-existing CKD in a variety of domestic and laboratory animals, including mice, 
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rats and dogs (28). A high consumption of salt and animal proteins has also been linked to 
progression of CKD in humans (12, 29), with increasing evidence indicating a greater effect of 
red meat consumption compared with that of other animal and vegetable protein sources (12, 
13).  
Whether high-protein diets can induce de novo renal disease is less certain. One study 
reported that a commercial diet low in potassium and high in meat (40% protein) and 
phosphoric acid led to the development of tubulointestitial lesions in five of nine domestic cats 
(30). In a human study, maintenance of a high-protein diet for 6 weeks increased estimated 
glomerular filtration rate (eGFR) by 4 ml/min/1.73 m² compared with a carbohydrate and 
unsaturated fat diet in healthy individuals (31); however, whether long-term consumption of a 
high-protein diet promotes CKD is unclear. Although felids are obligate carnivores, their dietary 
acquisition of protein in the wild is intermittent and separated by days of fasting (25). By 
contrast, domestic cats and felids kept in zoos are often fed high-protein diets on a daily basis.  
An examination of published data on 12 biochemical parameters of serum that can be 
used to evaluate renal functions in 97 mammalian species shows that differences in patterns of 
these parameters result in a clustering of species, separating carnivorous mammals from 
omnivorous or herbivorous mammals (Supplementary information S2 (figure)). This clustering 
is mainly due to higher levels of urea (+57%), and chloride (+13%), as well as reduced levels of 
alkaline phosphatase (-56%) among carnivores compared with mean values of the other 
species. This finding highlights the importance of diet, including protein source, on parameters 
of renal function, and leads to the hypothesis that in humans, different types of diets (for 
example, vegetarian or highly carnivorous) might lead to similar differences in parameters of 
renal function(s). 
  Although the classic view is that renal injury induced by a high-protein diet is caused by 
changes in glomerular haemodynamics  (32) (Figure 2), increasing evidence suggests that CKD 
risk is associated with protein originating from red meat and not with protein from dairy or 
vegetable-based sources (33). For example, epidemiological studies conducted in Singapore 
(34) and the USA (35) (36) have shown that among different protein sources (including red 
meat, poultry, dairy products, fish eggs and legumes) only red meat (beef, pork and lamb) and 
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processed meat increased the risk of CKD. In one study, individuals in the highest quartile of 
dietary red-meat intake had a 1.4-fold greater risk of end-stage renal disease (ESRD) than those 
in the lowest quartile of red-meat intake (34). Interestingly, diets rich in other protein sources, 
such as legumes and low-fat dairy products, were actually protective against CKD (35). Red and 
processed meat therefore seem to have direct nephrotoxic effects that increase the risk of CKD. 
Indirect support for differences in plant and animal proteins comes from studies in vegetarians. 
A study conducted in Taiwan showed that eGFR did not differ among 102 vegetarian Buddhist 
nuns compared with an equal number of age-matched omnivorous females (37) However, 
serum levels of sodium, glucose, urea and cholesterol, as well as blood pressure and urinary 
specific gravity, were lower among individuals in the vegetarian group (37). As vegetable 
proteins have different renal effects (lower GFR and renal plasma flow) than meat proteins (38), 
and plant-based diets might protect against the development of CKD (39) and its complications 
(40), patients with CKD should be encouraged to consider a vegetarian diet (41).  
In addition to CKD, red and processed meat have been linked to an increased mortality 
(42) and risk of other chronic diseases, such as cancer (43), stroke (44), coronary heart disease 
(45) and type 2 diabetes mellitus (T2DM) (46). Moreover, one study reported that the 
withdrawal of red meat from the diet of patients with T2DM reduced albuminuria and 
improved their serum fatty acid profile compared with their usual diet (47). Another study in 
patients with T2DM showed that adherence to a chicken meat-based diet for 1 year reduced 
urinary albumin excretion to levels comparable to those achieved by treatment with an 
angiotensin-converting enzyme (ACE) inhibitor (48). These findings imply that renal toxicity is 
generated by red meat per se, and not total protein intake. Dietary management of CKD in 
domestic cats with a low-protein and low-PO4 diet was associated with increased survival 
compared with that of cats that did not undergo the dietary change (49). Further investigation 
is required to elucidate potential differential effects of processed red meat, game meat and 
white meat (that is, chicken or fish) on renal function in felids.  
 
[H3] Mechanism of red meat-induced CKD. Several factors have been proposed to be implicated 
in the disease-promoting effects of red meat (50) (Figure 2). These include an associated high 
  8 
intake of NaCl (which increases blood pressure and stimulates vasopressin production and 
release by increasing serum osmolality), saturated fats (which drive mitochondrial oxidative 
stress), increased net acid production (which causes metabolic acidosis and acidic urine), the 
pro-oxidative effects of haem iron (which promotes oxidative stress), DNA damage caused by N-
nitroso compounds , (which leads to purine degradation and uric acid formation), the 
incorporation of non-human sialic acid into tissue (which promotes interaction with 
inflammation-provoking antibodies) and changes in the composition and/or metabolism of gut 
microbiota. For example, trimethylamine-N-oxide (TMAO) - which is produced from the 
metabolism of red meat, eggs and fish by gut microbiota - induces renal fibrosis in animal 
models (51) and inflammation in endothelial cells (52). Although diminished renal function 
impairs the ability to eliminate TMAO, it predicts outcome in patients with CKD even after 
adjustment for other risk factors (53). Inhibition of gut microbial trimethylamine (TMA) 
production prevented the development of atherosclerotic lesions in Apoe–/– mice (54). 
Moreover, exposure to carnitine (a major nutrient in red meat) in mice affects the composition 
of gut microbiota via the proatherogenic intermediate -butyrobetaine that is converted into 
TMA and TMAO (55). Alterations in gut microbiota might also affect processes, such as haem-
induced lipoperoxidation (56). Red meat consumption is also associated with increased intake 
of phosphate, which is associated with decreased renal function, inflammation and premature 
ageing (57). Moreover, phosphate activates nuclear factor-B (NF-B) signalling and promotes 
the generation of reactive oxygen species (ROS) in vascular smooth muscle cells (VSMCs) (58). 
This observation implies that the putative protective effects of antioxidative factors, such as 
nuclear respiratory factor (NRF2) (Box 1), on renal function should be investigated in the 
context of a diet rich in red meat.  
 The high content of nucleic acids in animal proteins probably also contributes to the 
nephrotoxic effects of red meat diets in humans and felids. Animal proteins are much more 
likely to raise serum uric acid levels than are proteins from vegetable and dairy sources (59). In 
domestic cats, a transient (up to 50-fold) increase in urine uric acid occurs following the 
ingestion of purine-rich animal proteins compared with a purine-free diet, despite the presence 
of a uric acid-degrading enzyme (uricase) (60). In humans, consumption of animal proteins 
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and/or purines also results in an acute rise in serum and urine uric acid levels (61, 62), which is 
accompanied with a substantial acid load in urine that leads to a decrease in urine pH (13). A 
urine pH of <5 is extremely common in cats with uraemic manifestations (23), and a low urine 
pH (5.0–5.5) predicts stage 3 CKD in humans (63). Although urate stones are relatively rare in 
cats (64), urate crystalluria is a common problem in felids (65). Coupled with dehydration and 
heat exposure, we propose that urate crystalluria and/or uricosuria resulting from high protein 
intake could facilitate tubulointerstitial injury. Both soluble and crystalline forms of urate have 
been shown to induce inflammation in rat tubular cells in vitro (66). Indeed, signs of 
dehydration in felids with CKD is common (23) and predictive for the development of CKD in 
domestic cats (67). In humans, although the aetiology of CKD in populations from Central 
America and Sri Lanka remains a subject of debate (68), we propose a role for heat stress and 
recurrent dehydration in the presence of high uric acid levels in disease pathophysiology (69) .  
 
[H2] Protein metabolism in vampire bats. Vampire bats (Desmodus rotundus) feed mostly on 
the blood of warm-blooded mammals. However, in contrast to man and felids, they seem to be 
resistant to the detrimental metabolic effects of a high-protein intake. Their protein intake 
would be comparable to a daily intake of about 6 kg protein in a 70-kg man (as compared to a 
normal daily intake of 50–120 g in humans). As the consumption of >20 g of blood in a 20-min 
feed increases the body weight of vampire bats by 20–30%, they rapidly absorb the blood 
plasma and start urine production within 2 min of feeding (70). The blood urea concentration of 
vampire bats is 27–57 mmol/L (compared with 3–8 mmol/L in healthy humans), depending on 
the time point after feeding (71). Despite this high protein intake, the vampire bat does not 
have larger kidneys than mammals of similar size (72), which suggests no difference in 
glomerular number and glomerular capillary surface area. Indeed, indirect allometric 
calculations indicate that the vampire bat's GFR is not greater than that of similarly sized 
mammals (71); however, to our knowledge, GFR measurements have not been carried out. Of 
interest, mammalian blood has a lower relative purine content than does red meat (73); 
however, whether this difference accounts for the differential risk of CKD between felids and 
vampire bats is speculative. 
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[H1] Ageing and longevity  
Ageing has been defined as an accumulation of deficits occuring in different individuals in 
different ways, and with varied rates in different organs (74). Ageing is an actively regulated 
process influenced by genetics, epigenetics, lifestyle, nutrition and psychosocial factors (75), 
which may act synergistically, independently or cumulatively. The ageing process is 
characterized by a series of hallmarks, including genomic instability, telomere attrition , 
epigenetic alterations, loss of proteostasis, dysregulated nutrient sensing, stem cell exhaustion, 
mitochondrial dysfunction, altered intercellular communication and cellular senescence (76), 
which are common across different taxa and affected by the uraemic milieu (75) (77) (78).  
  
[H2] Ageing and kidney disease. In addition to the progressive loss of renal function, ageing in 
humans, rats and many other mammals is associated with the development of 
glomerulosclerosis and interstitial fibrosis (79, 80), which are linked to impaired autoregulation 
of renal blood flow and impaired angiogenesis, epigenetic modifications, endothelial 
dysfunction, oxidative stress and inflammation (75). Chronic inflammation (also known as 
‘inflammageing’) is an important driver of premature uraemic ageing (81) and manifests with an 
increased frequency of age-related complications, such as vascular stiffening, osteoporosis, 
muscle wasting, depression, cognitive dysfunction and fraility (81). In addition, persistent 
mitochondrial dysfunction with increased generation of ROS features in both normative ageing 
(82) and progressive CKD (83).  
 Whether ageing-associated renal disease is inevitable (84) or modifiable (85) remains 
controversial. The use of senolytic agents , which selectively remove senescent cells , in pre-
clinical models suggests that ageing-associated renal disease is modifiable (77), and direct 
improvement of physiological function following removal of these cells indicates causality. 
These cells are non-proliferative, resistant to apoptosis and are generated in response to 
genotoxic stress and resulting DNA damage, as part of normative ageing. Loss of age-related 
regenerative capacity in tissues and organs occurs as a direct consequence, and a senescence-
associated pro-inflammatory milieu subsequently develops. The selective removal of senescent 
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cells from tissues and organs via immune-mediated clearance is dysregulated during normative 
ageing, and contributes to inflammaging (86). The accumulation of these cells has been 
observed across a broad spectrum of non-communicable diseases.  
  
[H2] Ageing in the animal kingdom. One way to improve our understanding of ageing processes 
and senescence is to study animals with unusual longevity. Long-lived animals are found across 
the taxonomic spectrum, such as in certain mammals, birds, sea turtles and fish. For example, 
extreme longevity is observed in the ocean quahog (Arctica islandica; >500 years) (87) and the 
Greenland shark (Somniousus microcephalus; ~400 years) (88). The study on the ocean quahog 
supports the notion that chronic low-grade inflammation in the cardiovascular system is an 
ubiquitous feature of ageing (87). Other interesting candidates for studies of reduced 
senescence include the rougheye rockfish (Sebastes aleutianus) and the bowhead whale 
(Balaena mysticetus), both with documented life spans of >200 years. Interestingly, ageing 
rockfish do not show signs of organ degeneration or a decline in liver lysosomal function (89), 
which are typically observed in normative ageing. By contrast, examples of exceptionally short-
lived species that exhibit an accelerated expression of ageing biomarkers are found in the 
family of Cyprinodontidae (killifish), which have a maximal lifespan of only 13 weeks (90). Thus, 
a better understanding of the mechanisms by which some animals have delayed or accelerated 
ageing processes (91, 92) may provide insights into not only the process of ageing in humans 
but also ageing-related kidney disease.    
[H3] Insights from the naked mole rat. Naked mole rats (Heterocephalus glaber) have emerged 
as a good model organism to study ageing and ageing-related diseases. These subterranean 
rodents are rarely exposed to sunlight and have no obvious dietary source of vitamin D (93). 
However, despite having undetectable calcifediol levels (the precursor of vitamin D), their 
calcium phosphate homeostasis is adequately maintained (94). Although they have a small 
body size and are constantly exposed to hypoxia, oxidative stress and hypercapnia, they can live 
>30 years and maintain a healthy cardiovascular and reproductive status as well as body 
composition throughout their life (5). Interestingly, the structure and function of their proteins 
is not affected by their substantial exposure to oxidative stress (95), and they display high levels 
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of autophagy and efficient removal of stress-damaged proteins throughout life (96). In contrast 
to humans and other rodents, (97) these animals preserve normal vascular and cardiac function 
with ageing (98, 99) and are resistant to the development of cancer (100). Moreover, their bone 
mineral density, articular cartilage and nitric oxide sensitivity of VSMCs is not affected by ageing 
(101). Whereas most nephropathologies seem to be absent in naked mole rats, cases of 
nephrocalcinosis have been reported (102).  
 
[H3] NRF2-mediated antioxidant activity. Some of the molecular pathways that protect these 
animals from cancer have been elucidated. For example, one study reported that the 5-fold 
higher production of high-molecular-weight hyaluronan  in fibroblasts protects naked mole rats 
from cancer (103). High expression levels of the transcription factor NRF2, which stimulates 
intracellular antioxidant activity by regulating the expression of many target genes involved in 
the antioxidant response (Box 1), may also protect the naked mole rat from cellular damage. In 
addition to antioxidative activities, NRF2 has other important functions, such as regulating 
nuclear factor B (NF-B) activity, which may play a part in mitochondrial homeostasis (104) 
and may decelerate the ageing process (105). As NRF2 expression correlates positively with 
maximum lifespan in long-lived rodents (106), diminshed NRF2 activity may be important for 
the ageing phenotype of organisms as diverse as worms, flies and mammals (107) .  
Evidence for a role of NRF2 in ageing has also been reported in humans. For example, 
children with the rare Hutchinson Gilford Progeria Syndrome (HGPS), which is caused by a 
mutation in prelamin A/C, age extremely prematurely, are subject to increased oxidative stress 
and have a repressed NRF2 pathway (108). As reactivation of NRF2 reversed the cellular ageing 
defects in HGPS patient cells and in an animal model of HGPS repression, NRF2-mediated 
transcription seems to have a pathogenic role in the progeric phenotype (108). As HGPS shares 
many features common to age-associated diseases it has been regarded as a model system to 
better understand ageing processes in chronic diseases (109). For unknown reasons at present, 
children with HGPS do not seem to have an increased risk of CKD despite a prematurely aged 
phenotype, which may reflect a feature of antagonistic pleiotropy (109). Despite apparent 
differences in the pathways underlying HGPS and CKD, we suggest that models of ageing and 
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longevity, such as HGPS and the naked mole rat, can be used to study factors that underlie 
progeric processes in CKD (Figure 3).  
 
[H2] Vascular calcification and phosphate  
[H3] Phosphate and calcification in vertebrates. The composition of seawater is similar to that 
of the human body in regard to the abundance of elements (110) (Supplementary information 
S2 (Table)), consistent with the view that life originated from the sea (111). Of the 10 most 
abundant elements in the human body, only phosphorous is not among the 10 most abundant 
elements present in sea water (112), indicating that organisms selectively accumulated 
phosphorus (in form of phosphate within cells) at some point in time during evolution 
(Supplementary information S4 (figure)). Phosphate is a major component of nucleic acids and 
membrane phospholipids, and has a key role in numerous intracellular functions, including ATP 
synthesis and function and kinase-mediated signal transduction (113). Phosphate is so 
fundamental to life that its deficiency can be fatal, which may be a reason for the evolution of 
‘phosphate appetite’ (114).  
 Although intracellular phosphate is essential to all forms of life, accumulation of 
extracellular phosphate first emerged in bony fish during the evolution of skeletons (115). 
Unlike invertebrates, which have a calcium carbonate (CaCO3)-based exoskeleton, most 
skeletons of vertebrates consist of calcium and phosphate, especially in the form of calcium 
hydroxyapatite (Ca10(PO4)6(OH)2) (116). This acquisition was likely required for terrestrial 
vertebrates to support their body weight on land. The extracellular fluid of vertebrates consists 
of a highly saturated solution of calcium and phosphate (117), which enables bone formation 
simply by controlling where to provide a ‘cue’ for nucleation of calcium phosphate, such as 
production and secretion of bone matrix proteins by osteoblast lineage cells. Undesired 
nucleation within the extraosseous tissues is achieved by maintaining extracellular phosphate 
concentration within a narrow range, in a process that is partially controlled by fibroblast 
growth factor 23 (FGF23) and its obligate co-receptor Klotho (encoded by Kl) (115). 
Interestingly, Kl-knockout mice have a 12-fold reduction in lifespan and a 2-fold increase in 
extracellular phosphate concentration compared with wild-type mice (118). Secreted Klotho 
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also exerts multiple functions independently of FGF23, such as inhibition of insulin-like growth 
factor 1 activity and upregulation of anti-oxidant enzyme expression levels. These additional 
functions may contribute to the anti-ageing properties of Klotho (119). Furthermore, Klotho 
induces NRF2 expression and subsequent anti-oxidant defence mechanisms (120), which links 
altered NRF2 expression to bone mineral metabolism and phosphate homeostasis (121).  
 
[H3] Phosphate in ageing and calcification. Vascular calcification is a common feature of the 
progeric uraemic phenotype (122) and linked to senescence (123). High extracellular phosphate 
levels, which often occur in combination with elevated calcium levels, increase the risk of 
calcium phosphate deposition in the vasculature and vascular calcification (122). Cell culture 
studies have shown that a high phosphate concentration induces cellular senescence (124) and 
leads to the conversion of VSMC to osteoblastic cells (125, 126); a process that can be 
prevented by inhibiting calcium phosphate precipitation by pyrophosphate, phosphonoformic 
acid (127, 128) and phosphate-binders (129). Consistent with the observation that a high 
phosphate concentration induces cellular senescence and that accumulation of senescent cells 
accelerates ageing of the organism (130) a negative correlation exists between extracellular 
phosphate levels and longevity across mammalian species (131) (Supplementary information S4 
(figure)). For example, children with HGPS have elevated phosphate levels, develop rapid 
vascular calcification and typically die of stroke or myocardial infarction as teenagers (132). 
Furthermore, expression of progerin (the mutated form of prelamin A associated with HGPS) in 
VSMCs leads to a decrease in extracellular pyrophosphate (133). As pyrophosphate protects 
VSMCs from calcification, high serum phosphate and low extracellular pyrophosphate may 
contribute to accelerated vascular calcification in HGPS. In the general population, high 
phosphate levels are associated with premature vascular ageing (134), shortened telomere 
length, reduced DNA methylation content and elevated IL-6 (57), which are all biological 
markers of ageing.  
Studies from the past few years have provided insights into the mechanisms by which 
high extracellular phosphate levels lead to vascular calcification. Under conditions of 
inflammation, oxidative stress and high extracellular phosphate levels, nanoparticle calcium 
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phosphate precipitates can develop in the vasculature, despite the presence of multiple 
endogenous inhibitors of calcium phosphate deposition (135, 136) and can grow to form 
calciprotein particles (CPPs). CPPs are aggregates of serum protein fetuin A (also known as 
AHSG) loaded with calcium phosphate precipitates and dispersed as colloids in the blood. These 
CPPs may play a part in CKD progession, as recent clinical studies showed that serum CPP levels 
correlated with vascular calcification and/or stiffness (135, 137), and predict mortality in 
patients on dialysis (138). Of interest, tigers have particularly high levels of phosphate (1.7±0.3 
mmol/L) and serum creatinine (265±62 µmol/L), suggesting it would be of interest to determine 
levels of serum CPP and FGF23 in these animals (139).  
  
[H3] Therapeutic strategies to prevent vascular calcification in CKD. The best current approach 
to prevent vascular calcification in CKD is dietary phosphate restriction or chelation through the 
use of phosphate binders (140). However, a consequence of dietary phosphate restriction is 
reduced protein intake, which can lead to protein–energy wasting and inadvertently increased 
mortality (141). A major problem with phosphate binder therapies is patient non-adherence 
due to the high pill burden and gastrointestinal adverse effects (142). Alternative treatment 
strategies to prevent vascular calcification could potentially be derived from comparative 
physiology studies. For example, agents that stimulate NRF2 (Box 1), block mTORC1 signalling 
(143) or reduce phosphate absorption, such as by inducing calcium phosphate precipitation in 
the gut with magnesium (144), should be tested for their ability to decrease extracellular 
phosphate levels.  
  Of interest, a diet of highly fermentable carbohydrates (for example, starch) in captive 
ruminants, such as giraffes (Giraffa camelopardalis) — in combination with low calcium, high 
phosphate and low magnesium levels in the serum — is associated with premature death in 
these animals (145). Since introduction of a diet with lower starch content, led to higher 
magnesium and lower phosphate levels (145), one potential approach would be to use 
‘resistant starch’, which is a complex carbohydrate fermented by gut microbiota that increases 
colonic absorption of minerals in animals. Indeed, resistant starch has been suggested to be a 
novel dietary method to prevent diabetic CKD (146).  
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[H2] Caloric restriction and ageing. Although dietary phosphate restriction is one mechanism to 
slow vascular calcification and ageing, a more effective approach to extend the lifespan of 
animals is by caloric restriction  (147), which has demonstrated efficacy in both short-lived 
species, including flies, worms, rats, mice (148), and more long-lived species, such as primates 
(149). Fat stores, especially those generated during fructose metabolism, result in fructose-
induced oxidative stress, which is associated with increased translocation of NRF2 to the 
nucleus, decreases in mitochondrial DNA content and mitochondrial dysfunction, with 
subsequent cellular apoptosis (150, 151). In most animals, excess fat stores are maintained as a 
protective mechanism for periods of food shortage (152). Thus, as long as food is available on a 
daily basis, caloric restriction would be expected to reduce mitochondrial oxidative stress and 
preserve mitochondrial metabolism. Other ways to mimic caloric restriction would be to 
administer agents that modulate cellular metabolism, including sirtuin  agonists (153, 154) and 
AMPK agonists (155), the effects of which are mediated in part by the activties of FOXO family 
and the insulin signalling pathways (156). For example, resveratrol prolongs lifespan in the 
extremely short-lived killifish (90). We found that mice that cannot generate fructose, which are 
therefore protected from mitochondrial oxidative stress, were also protected from developing 
age-related renal disease (157). In theory, elevated expression of NRF2 also mimics caloric 
restriction, as knockdown of KEAP1 in mice results in accumulation of NRF2 and thus augments 
the activation of cellular stress responses, including fatty acid oxidation and lipogenesis (158) . 
  
[H3] Methionine restriction and ageing. In addition to caloric restriction, dietary restriction of 
proteins — especially the sulphur-containing amino acid methionine — also promotes longevity 
in various animal models (159) (Figure 4). This effect is likely to be mediated through the 
cytoprotectant hydrogen sulphide (H2S) gas and increased activation of the transsulphuration 
pathway , prevention of electron leakage from mitochondria, and possible hermetic effects on 
the mTOR pathway and NRF2 activity (160). Under conditions of cellular stress, H2S-mediated S-
sulfhydration of KEAP1 leads to its disassociation from NRF2 and enhanced NRF2 nuclear 
translocation. (Box 1) This increases mRNA expression of NRF2-targeted downstream genes, 
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such as glutamate cysteine ligase (GSH1) and glutathione reductase and upregulates a range of 
cellular defenses. In addition, methionine restriction increases expression of the 
transsulphuration pathway enzyme cystathionine γ-lyase (CTH), resulting in increased H2S 
production, which leads to AMPK activation and mTORC1 repression, thus reducing cellular 
stress and promoting physiological longevity (161). H2S also binds iron and captures electrons 
leaked from mitochondria, which reduces mitochondrion-mediated ROS formation (162, 163). 
In support of a role for H2S activity in longevity, lower circulating methionine levels have been 
reported in naked mole rats compared with levels in shorter-lived laboratory rodents (164). The 
recent finding of low sulphide levels in naked mole rats and the inverse correlation between 
circulating sulphide levels and maximum longevity in six different species (165) add to 
complexity of understanding the role of H2S in ageing. Thus, for prolonging life span, 
interconnections between methionine and caloric restriction in the context of comparative 
biology need to be investigated further.  
 Methionine restriction might be particularly important in preventing ageing and age-
associated renal dysfunction (57). For example, an inverse correlation between methionine 
content in tissue proteins and longevity was reported in eight different species (166). Although 
circulating methionine levels do not differ between patients with CKD and healthy controls 
(167), oral methionine loading in patients on haemodialysis leads to an accumulation of 
homocysteine and other methionine metabolites in plasma and red blood cells, indicating 
impairment of the transsulphuration pathway. High doses of vitamin B6 and folic acid failed to 
mitigate this phenotype, indicating that it most probably was not due to a lack of these co-
factors (168). Methionine restriction also increases the replicative lifespan and decelerates the 
accumulation of senescent cells across taxa from yeast to man (169). Consistent with these 
observations, we reported lower methionine levels in wild brown bears (Ursus Arctos) (8) and 
observed a 4-fold increase in the methyl donor betaine during hibernation (P.S. et al., 
unpublished work). Thus, it could be speculated that an increased production of H2S protects 
the bears from ROS-mediated DNA damage. Moreover, dietary supplementation of H2S in mice 
alleviates inflammation, abberant methylation and dysfunction in a model of hypertensive 
kidney disease (170), suggesting this cytoprotective gas should be investigated as a novel 
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treatment strategy in CKD. A diet rich in one-carbon methyl donor units relative to calories, 
such as betaine (found in fruits, cereals and vegetables) can be used as an epigenetic switch 
and, via DNA hypermethylation and transmethylation in the methionine cycle, promotes 
longevity (171). This mechanism merits further investigation, as low betaine levels have been 
observed in humans with poor renal function and accelerated biological ageing (P.G.S. et al., 
unpublished work). 
 
[H1] Hypoxia and ischaemia  
Naked mole rats survive constant exposure to hypoxic conditions by generating ATP through 
glycolysis. This process is mediated in part by using endogenously produced fructose, which 
preferentially stimulates glycolysis and lactate production (172). We have found that fructose 
metabolism commonly leads to glycogen accumulation in the liver in mice and rats (R. J. J. and 
M.L., unpublished work). This metabolic mechanism might also protect the kidneys of diving 
marine mammals that are subject to periods of prolonged hypoxia during deep dives. Harbour 
seals (Phoca vitulina) and whales (Cetacea) for example, have large amounts of glycogen in 
their proximal tubules, along with high levels of glycolytic enzymes to generate ATP during 
hypoxia (173, 174). The kidneys of Weddel seals (Leptonychotes weddellii) are protected from 
hypoxia despite severe renal vasoconstriction upon diving (175). Likewise, kidneys of 
hibernating squirrels are protected from ischaemic injury, in a process that is probably 
mediated via an abscence of caspase-3-like mediated activity (176).  
 One potential mechanism by which glycolysis protects against hypoxia could occur 
through the upregulation of antioxidants. Fasting seals have high expression levels of NRF2, 
(177) antioxidant enzymes (178) and glutathione levels (179) compared with the non-fasting 
state. In support of a protective role for antioxidants, hyperactivation of NRF2 prevents 
progression of tubular damage after renal ischaemic injury in mice (180). Thus, NRF2 might be a 
therapeutic target to prevent acute kidney injury and could activate a hypoxia survival pathway 
(Box 1). By contrast, very high intracellular concentrations of dietary or endogenously produced 
fructose leads to rapid and transient ATP depletion, resulting in a strong pro-inflammatory 
response and substantial oxidative stress in human proximal tubular cells (181). Indeed, a high-
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fructose diet inhibits KEAP1–NRF2 antioxidant signalling and increases the risk of non-alcoholic 
hepatosteatosis in mice (182). Thus, high concentrations of fructose may be injurious whereas 
low concentrations may carry survival functions. 
 Last, although hypoxia and ischaemia usually occur in conjunction, some species, such as 
the turtle are tolerant to hypoxia but still sensitive to brain ischaemia (183). A better 
understanding of hypoxic tolerance in turtles and naked mole rats may provide novel 
therapeutic interventions to combat the harmful effects of cerebral, renal and cardiac 
ischaemia in humans.  
[H1] Seasonal acclimatization and hibernation 
 [H2] Seasonal acclimatization of metabolic activity. Many small mammals escape food shortage 
during winter by hibernation or daily torpor  (184). Other species that do not hibernate or go 
into daily torpor in the classical sense, such as red deer (Cervus elaphus) or Alpine ibex (Capra 
ibex), adopt a similar hypometabolic state during winter. The reduction in energy expenditure is 
therefore, similarly to hibernators and species undergoing daily torpor, mainly accomplished by 
lowering endogenous heat production and increasing the tolerance to a lower body 
temperature. Although the 2–3°C change in core body temperature is only moderate (185, 186) 
a substantially lower body temperature down to 15°C is present at the body’s periphery (187), 
which is indicative of a substantial reduction in the mean temperature of the entire body mass. 
The winter phenotype of mammals further includes a shift from an anabolic metabolism during 
summer to the use of body fat reserves to fuel metabolism during winter (188, 189). As a result, 
many hibernators do not eat during winter (188), and non-hibernating species like red deer 
reduce their food intake substantially, even when fed ad libitum (190). The endogenous nature 
of the seasonal cycle of appetite and its entrainment by photoperiod has been shown 
experimentally for many wild species (191). Decreased food intake during winter leads to a 
reduction of the size of the gut and visceral organs, like the kidney (190, 192), which further 
contributes to lower energy expenditure. 
 Major differences exist in levels of serum biomarkers of microbiota metabolites between 
wild bears and bears in captivity (P.S., unpublished work), suggesting that nutrients and feeding 
patterns might contribute to the metabolic changes required for hibernation. A transition in 
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energy metabolism from carbohydrates during summer to lipids during winter is facilitated by a 
switch from insulin sensitivity in the summer to insulin resistance during hibernation (193). The 
observation that central administration of leptin to captive grizzly bears leads to reduced food 
intake in October, but not in August, implies that seasonal variations exist in the sensitivity of 
the bear brain to the anorexic effects of leptin (193). In addition, seasonal variations in gut 
microbiota might also contribute to changes in energy metabolism in hibernating bears, as 
transplantation of summer gut microbiota from wild bears promoted adiposity without 
affecting glucose tolerance in germ-free mice (194). Although humans do not hibernate, 
investigating the processes that trigger fat accumulation in the summer followed by the switch 
to reduced energy intake and a fat-burning state occuring immediately before animals 
hibernate (195) may help to understand the mechanisms driving obesity.   
 [H2] Seasonal changes in membrane composition. Seasonal variation in body temperature is 
preceded by changes in the composition of cellular membranes, which consists of the 
integration of nutritionally acquired polyunsaturated fatty acids (PUFAs) into phopsholipids 
during periods of cold acclimatization (196). In addition to seasonal changes, even daily 
rhythmic changes in the phospholipid fatty acid composition of membranes have been found in 
humans along with changes in body temperature (197). Furthermore, physical exercise can 
alter the lipid composition of membranes, for example by increasing the concentration of 
docosahexaenoic acid (DHA) in skeletal muscle phospholipids (198) and by enhancing insulin 
sensitivity, probably through increasing insulin receptor expression levels. Of interest, the 
composition of membrane phospholipids has also been reported to contribute to the 
outstanding longevity in naked mole rats (199). 
 The composition of membrane lipids influences the activity of membrane-bound 
enzymes, for example, sarcoplasmic reticulum Ca2+-ATPase (SERCA) activity is increased in 
membranes that are rich in linolenic acid (LA). Therefore, incorporation of LA into phospholipids 
of cardiac myocytes can compensate for reduced SERCA activity due to low temperatures and 
enable adequate Ca2+ handling in cardiac myocytes even at body temperatures close to freezing 
point (196, 200). High concentrations of LA in membranes also improve muscle performance at 
a high body temperature, as suggested by a positive relationship between LA content of 
  21 
membrane phospholipids of muscle cells and maximum running speed, found in a comparative 
study of 36 mammal species (201). By contrast, DHA incorporation into phospholipids 
decreases SERCA activity (200) but seems to increase the activity of key enzymes of the Krebs 
cycle and fatty acid ß-oxidation (202). Accordingly, an increase of the DHA content into 
phospholipids during hibernation in Alpine marmots is paralleled by an increase of thermogenic 
capacity (196).  
As all PUFAs are of dietary origin in mammals and birds, uptake influences the fatty acid 
composition of membranes. However, the balance of ω-6 to ω-3 PUFA in phospholipids seems 
to be regulated more by deacylation/reacylation processes, that is, membrane remodelling, 
rather than directly by dietary intake (190, 203). The different effects of ω-6 and ω-3 PUFA on 
membrane-bound enzymes hint at intriguing molecular conflicts. There probably is no optimal 
“all-purpose” PUFA composition in tissues, which creates a trade-off between costs and 
benefits of each fatty acid that is influenced by metabolic state, for example fasting or 
fattening, and hence is subject to seasonal and even daily variations (190).  
In rats with adenine-induced CKD, a pro-inflammatory fatty acid pattern (low PUFA and 
high saturated fatty acid concentrations) was associated with downregulation of NRF2 activity 
and increased activation of NF-B and its downstream cytoprotective and anti-oxidant proteins 
(204). As oxidation of eicosapentaenoic acid and DHA generate concentrations high enough to 
induce NRF2-directed gene expression (205), this may explain the anti-oxidative and anti-
inflammatory properties of -3 PUFAs. Burmese pythons (Python molurus) were reported to 
display 40% cardiac hypertrophy with increased cardiac output 48–72 hrs after large meals 
(206). Since consumption of these meals activates expression of fatty acid transport pathways 
and cardioprotecive enzymes, and injection of a combination of python fatty acids found in 
plasma promotes physiological hypertrophy in mammalian cardiomyocytes (207), targeted fatty 
acid supplementation may be a novel strategy to modulate cardiac gene expression and 
function in heart failure .  
 [H2] Circadian clock and kidney functions. Oscillating molecules that regulate circadian clocks is 
common in most if not all animal species (208). Disruptions of the circadian clock  leads to 
metabolic syndrome with dyslipidaemia, hyperleptinaemia, hyperglycaemia and hepatic 
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steatosis in Clock–/–mice (209). As the circadian clock activates NRF2–gluthatione-mediated 
antioxidant defense pathways and arrhythmic Clock∆19 mice have low NRF2 expression (210), 
this network might have an important role in regulating energy balance and anti-oxidative 
protection. Circadian fluctuations are also known to affect renal blood flow, glomerular 
filtration, blood pressure and water and sodium excretion (211). Thus, whether CKD 
progression is affected by circardian disruption and the potential benefits of chronotherapy  
should be investigated (212). In addition, further investigations are warranted into the reasons 
for seasonal variations in the incidence, progression and mortality of ESRD (213). 
 
[H2] Insights from hibernating bears. Osteoporosis, poor wound healing, vascular disease, 
inflammation and muscle loss, together with substantial metabolic dysfunction (Figure 1), are 
common features of the uraemic phenotype (10). The metabolism of bears is suppressed to 
about 25% of basal rates during hibernation (195). Nevertheless, hibernating bears tolerate 
extended periods of an extremely low heart rate (~10 beats/min) (214) without developing 
congestive heart failure, atherosclerosis (215) thromboembolic events or cardiac dilation; which 
are common features in CKD. The protection against vascular disease may in part be mediated 
by changes in the coagulation pathway, in which traditionally intrinsic cascades (initiated when 
blood comes in contact with exposed collagen from damaged endothelial cells) are suppressed 
and extrinsic tissue factor pathways (initiated by vascular wall trauma) are maintained, to 
prevent thromboembolic events while enabling external injuries to be healed (216).    
The fact that hibernating bears do not develop azotaemia or uraemic complications (8) 
is remarkable, considering that they have a 90% reduction in renal blood flow, anuria (70–180 
ml of urine per day is reabsorbed through the urinary bladder wall (217)), mild hypothermia 
(30–36°C), a 50–70% reduction in GFR, and experience fasting and immobilisation for 5–6 
months of winter sleep. It is even more intriguing that females are able to give birth to cubs and 
nurse them during hibernation. Although a histological study in Romanian brown bears 
reported signs of glomerular fibrosis after awakening from wintersleep (218) the reduced renal 
function is normalised within weeks (8). Thus, studies of the profound metabolic changes that 
occur in bears from summer to winter may provide clues that point towards novel therapeutic 
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strategies for patients with CKD (7) (Figure 1). Bears and marine mammals have a reniculated 
kidney system (renal lobulation)  (Supplementary information S5 (figure)). Proximal convoluted 
tubules in multilobulated and reniculated kidneys are comparatively short, which decreases the 
resistance to intraluminal flow. The large body size in combination with the limitation of length 
of the proximal convoluted tubules (219), seem to be the most likely explanation for 
multilobulation of large terrestrial and marine mammalian kidneys. Similar to the protection 
from hypoxia during deep dives of seals, bears might benefit from reniculated kidneys during 
hibernation, when their blood flow is reduced. 
 
[H3] Applications for transplantation. Kidneys are particularly susceptible to ischaemic injury 
because of their high metabolic rate and oxygen consumption. Ischaemia–reperfusion injury is 
common in donor organs used for renal transplantation, in part due to mitochondrial 
dysfunction, oxidative stress, ATP depletion and apoptosis following rewarming of the donor 
kidney. Despite extensive and repetitive periods of low metabolism, starvation and low cardiac 
output (220) bears return from hibernation without signs of persisting organ damage. Hence, 
studying the molecular changes in hibernating bears may lead to novel pharmacological 
approaches that could mimic hibernation and limit organ damage during renal transplantation 
(220). As active suppression of metabolism during hibernation preceeds the lowering the body 
temperature it can be speculated that lowering the basal metabolic rate may be more effective 
at preventing ischaemia–reperfusion injury to the donor organ than would therapeutic 
hypothermia (195). Intriguingly, the metabolic switch(es) that occurs in preparation for 
hibernation shares features with the metabolic changes associated with longevity in the animal 
kingdom (discussed in further detail below) (221). Indeed, hibernating species have an 
approximately 15% higher annual survival rate compared with non-hibernators of similar size 
(222). The observation that animals initiate hibernation due to a lack of food (or other 
environmental cues) and not because of a lower body temperature (223), and terminate 
hibernation due to physiological factors (214), can guide future research on the ”metabolic 
switches” that induce and terminate hibernation.   
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On the basis of metabolic pathways that are altered in hibernation and associated with 
longevity approaches that might preserve organ function during transplantation could be 
proposed: for example, the cytoprotective gas H2S induces a torpor-like state in mice (224), 
protects against lethal hypoxia (225) and as mentioned earlier activates anti-inflammatory and 
anti-oxidant pathways via mTOR and Nrf2 (226). Thus, H2S treatment might confer organ 
cytoprotection via creation of a hibernation-like environment (238). Furthermore, injection of 
the AMPK agonist 5'-AMP, induces torpor independently of H2S (227), although the mechanism 
underpinning this observation remains to be defined. Therefore, pretreatment of donor organs 
with agents that inhibit inflammatory responses and activate anti-oxidant pathways, such as 
H2S gas, sirtuin agonists, mTOR inhibitors and AMPK agonists, might prevent renal ischaemia–
reperfusion injury more effectively than current approaches (228) (229).  
 
[H3] Applications for muscle wasting. The loss of skeletal muscle mass that can occur in patients 
with CKD is caused by a combination of sedentary behaviour , anorexia and the activation of 
catabolic pathways in the uremic mileu. In contrast to humans — whose muscle mass and 
strength may be reduced by >90% during extended periods of immobilization — hibernating 
black bears show minor loss in skeletal muscle cell number or size (230). One mechanism by 
which bears retain muscle strength is by de novo amino acid and protein synthesis from urea 
(231), coupled with a unique ability to recycle urea during hibernation that has not yet been 
observed in other hibernating animals (7). Metabolic recycling of nitrogenous waste products 
seems to be a conceivable mechanism to prevent loss of muscle protein (Figure 5). In addition, 
the skeletal muscle of hibernating bears seems more resistant to denervation  than skeletal 
muscle of non-hibernating bears (232), suggesting that hibernation is associated with changes 
in the neural regulation of skeletal muscle catabolic pathways, and that targeting these 
pathways could offer novel solutions for the treatment of disuse atrophy .  
The plasma of hibernating bears has an anti-proteolytic effect that inhibits wasting of 
isolated skeletal muscle (233). Serum–glucocorticoid-regulated kinase 1 (SGK1) is activated by 
insulin and growth factors and helps prevent loss of muscle mass via downregulation of 
proteolysis and autophagy and increased protein synthesis (234). As high SGK1 expression 
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levels have been reported in hibernating ground squirrels (235), mice lacking SGK1 have muscle 
atrophy (234) and low SGK1 expression levels are found in patients with CKD (236) this 
serine/threonine kinase may be a novel therapeutic target to prevent uraemic muscle loss. 
Moreover, expression levels of peroxisome proliferator-activated γ-receptor coactivator 1α 
(PGC1α), which activates metabolic pathways associated with endurance exercise (such as 
running), are induced by cold exposure (237) and are elevated in hibernating squirrels (238). 
This master regulator plays a major part in renal recovery from acute kidney injury through 
regulation of NADH synthesis (239). Hence, stimulation of PGC1αsuch as through exercise 
(240), might also promote skeletal muscle homeostasis in CKD. Since activation of NRF2 by 
sulforaphane also increases endurance exercise capacity (241) , multiple targets and pathways 
to prevent uraemic muscle loss exist.  
 
[H3] Applications for bone loss. In addition to being protected from muscle wasting, hibernating 
bears are protected from poor wound healing and osteoporosis. Unlike humans and other 
mammals (including small hibernating mammals), hibernating bears can withstand physical 
inactivity (mechanical unloading ) and nutritional deprivation for ≤6 months without any 
negative effects on bone strength (242). Maintenance of calcium homeostasis is considered the 
most important contributing factor in bone health, but many other factors, such as growth 
hormones and cytokines, also have a role. Hibernating bears maintain eucalcemia  during 
immobilization (8) and have decreased markers of bone resorption and formation (243), which 
indicates precise balancing of bone remodelling activity. The suppression of bone remodelling 
during hibernation is likely an important mechanism to conserve energy during a long period of 
inactivity, decreased renal function and fasting (204). Other contributing factors probably 
include the differential reglulation of gene expression and hypothalamic control of hormones 
involved in bone remodelling, as higher expression levels of hormones that reduce bone 
formation, such as cocaine and amphetamine-regulated transcript (CART) (243). An elevated 
expression of anabolic genes but not bone resorption genes (244), have also been reported.  
Changes in vitamin D metabolism may also preserve bone mass during hibernation (245). 
In contrast to humans, 25(OH)D-vitamin levels do not change between seasons in bears (246) 
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and bear kidneys continue to produce calcitriol (1,25(OH)2D3; the active metabolite of vitamin 
D) despite a marked reduction in renal function during hibernation (245). Black bear 
parathyroid hormone activates cAMP, mitigates apoptosis in osteoblast cultures and increases 
trabecular bone volume (247); hence, the anabolic effects of bear parathyroid hormone might 
also prevent disuse osteoporosis. In addition, NRF2 was reported to have a role in bone 
microarchitecture in a mouse model of osteoporosis (248) and inhibits receptor activator of NF-
B ligand (RANKL)-mediated osteoclastogenesis in osteolysis-induced mice (249). Given the fact 
that increased NRF2 expression plays a major part in the antioxidant defences that are required 
for hibernation success in ground squirrels (250), the potential role of NRF2 in maintaining 
skeletal mass in hibernating bears warrants investigation. Taken together, studies of 
hibernating bears can provide novel therapeutic approaches for the treatment of intracellular 
calcium disorders and prevention of bone loss during immobilization in humans. 
 
 [H3] Applications for wound healing. Bears also have the ability to heal wounds despite 
immobilisation, hypothermia and anuria — conditions that are usually unfavourable for wound 
healing (251). Elevated levels of δ-opioid receptor agonists and ursodeoxycholic acid have been 
linked to the wound-healing capabilities of hibernating bears (251), but further insights into the 
underlying mechanisms involved might provide strategies to enhance wound healing. Changes 
in the coagulation pathways that occur during hibernation (216) may also contribute to better 
wound healing.  
[H3] Applications for azotaemia. The unique ability of hibernating bears to recycle urea back 
into proteins not only protects the bear from muscle wasting but also from azotaemia (Figure 
5). Since little urea is generated during hibernation (252) minimal amounts of urine need to be 
excreted (231). When [14C] urea and heavy water (D2O) were administered into the bladder of 
hibernating bears, reabsorption of both isotopes occured across urothelia with rapid 
appearance in plasma (253). Although small quantities of solute and water transport across 
urinary tract urothelia is a feature of most mammalian species (254), the mechanism(s) by 
which bears accomplish this transport during hibernation remains unknown (254). One 
hypothesis is that the passage of recycled urea from the intestine contributes to de novo amino 
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acid synthesis, since urease-expressing gut bacteria release ammonia that can be used by the 
host to synthetize glutamine for protein synthesis (252). In contrast to bears, humans cannot 
recyle urea, and urea degradation in the human gut does not stimulate the conservation of 
nitrogen (255). In addition, glycerol prevents azotaemia in hibernating black bears by serving as 
a carbon source for de novo amino acid synthesis (256). As urea levels decrease in the autumn 
before hibernation (257), a dietary shift may contribute to this change. The metabolic 
regulation of fasting is, in part, mediated by the activities of sirtuin 5 (SIRT5). SIRT5 exhibits 
deacetylase, desuccinylase and demalonylase activities and regulates the urea cycle enzyme 
carbamoyl phosphate synthetase 1  (CPS1) in liver mitochondria. Since Sirt5–/– mice fail to 
upregulate CPS1 and exhibit hyperammonaemia during fasting (258), this implies a role for 
SIRT5 in urea metabolism and the metabolic regulation of fasting. Thus, the long-term effects of 
sirtuin activators, such as resveratrol, on urea handling should be tested in patients with CKD.  
 
 [H3] Protective compounds in berries. Bears can ingest up to 200,000 berries per day in peak 
season, which occurs in late summer (259). There is a synchronous timing of food resources 
that triggers to switch from salmon to berries during the summer (260). Blueberries  have 
potent anti-inflammatory and anti-oxidant properties (for example, through the actions of 
phenol-like antioxidants) and contain anthocyanins . Berries are also an important source of 
sirtuin agonists (such as pterostilbene and resveratrol), quercetin, vitamin K, vitamin C and 
fibers. In addition, berries contain fructose and linolenic acid that may stimulate fat storage in 
preparation for hibernation. Polyphenols are secondary metabolites in plants that are needed 
not only for plant growth but also as a defense mechanism against UVB exposure and agression 
by insects and fungal pathogens (261). In a mouse model of polygenic obesity, consumption of 
berries results in a shift in gut microbiota towards obligate anaerobes, which correlates with a 
decrease in gastrointestinal luminal oxygen and oxidative stress (262). Potential implications on 
human health of the nearly anoxic conditions observed in the mouse gut lumen after berry 
consumption should be investigated.  
In addition, resveratrol preserves bone mass in old male rats (263), anthocyanins in 
berries increases serum alkaline phosphatase levels in obese male mice (264) and the 
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anthocyanin delphinidin inhibits excessive osteoclastogenesis in a mouse model of osteoporosis 
(265). Notably, delphinidin also prevents muscle atrophy in mice (266) and lowers fasting 
glycaemia in prediabetic individuals (267). Moreover, dietary supplementation with 
anthocyanins isolated from roselle (Hibiscus sabdarrifa) attenuated progression of adenine-
induced CKD in rats (268). Since a causal role for senescent cells in ageing-related bone loss has 
been demonstrated in mice (269) nutritional compounds with senolytic effects , such as 
quercetin and fisetin (270) — found in fruits, capers, vegetables and berries — may also 
contribute to the capacity of bears to maintain their bone mass (242). Quercetin also blocks 
phosphate-induced apoptosis and VSMC calcification via inhibition of mitochondrial fission and 
oxidative stress (271). As polyphenols that stimulate sirtuins and PGC1α prevent muscle 
wasting induced by mechanical unloading (272) or in streptozotocin-induced diabetes in rats 
(273), their long-term effects should be tested in patients with CKD who experience muscle 
wasting. Resveratrol and grape seed proanthocyanidin extract facilitate VEGF expression and 
angiogenesis in different wound models (274). Hence, the long-term effects of sirtuin activators 
and antocyanins on wound healing require further investigation. In healthy humans and 
patients with the metabolic syndrome, blueberry supplementation decreases cardiovascular 
risk factors (275), increases HDL–cholesterol (276) and improves insulin sensitivity (277). 
Moreover, a study based on validated food-frequency questionnaires in 93,600 women (Nurses 
Health Study) showed that a high intake of anthocyanins (highest versus lowest quintile) was 
associated with a decreased risk of myocardial infarction (278). Finally, since many plants that 
are consumed by bears contain melatonin (279) the effect of plants, such as tall fescue (Setvca 
arundinaces), on the metabolic changes that occur between seasons in hibernating bears 
should be investigated further. Taken together, the potential beneficial effects of berries and 
other plants on the uraemic phenotype should be assessed. 
[H1] Conclusions 
Species living in extreme habitats have acquired adaptive mutations through natural selection 
and epigenetic calibration to survive in challenging environments. Environmental factors and 
stressors - such as infections, toxins, starvation, climate change and psychosocial factors - have 
modified the epigenetic landscape throughout evolution to enable dynamically responsive 
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changes in gene expression and associated biochemical networks to help mitigate the effects of 
these changes (75). Although humans have a common ancestry with mammals and share the 
same vulnerability to infections, environmental toxins and illnesses, most physicians have 
regarded animal diseases as different and of minor interest in the understanding of complex 
human diseases. However, almost all diseases that affect humans have an equivalent in the 
animal kingdom, although treatment options may differ. Thus, we propose a multidisciplinary 
approach to improve health care of patients with CKD by sharing new discoveries and tools 
from the fields of zoology, botany, ecology, veterinary medicine, anthropology and biology.  
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Key Points 
• Biomimetic studies of non-laboratory wild animals are useful for identifying mechanisms that 
protect or increase susceptibility to disease.  
• Domestic and captive felids are vulnerable to chronic kidney disease (CKD), supporting the 
hypothesis that a high-protein intake — particularly from red meats and in combination with 
dehydration — is nephrotoxic.  
• Extreme models of ageing, such as Hutchinson–Gilford Progeria syndrome and the naked mole 
rat, can be used to investigate the mechanisms of vascular progeric processes in CKD.  
• Current evidence suggests that elevated serum phosphate levels promote ageing and cellular 
senescence.  
• The transcription factor NRF2 may offer protection against diseases in extreme environmental 
conditions and may promote longevity in the animal kingdom; NRF2 agonists (such as resveratrol 
and sulforaphane) might improve the uraemic complications of CKD.  
• Lipid composition of membranes has a role in seasonal acclimatization of metabolic activities 
in the animal kingdom. 
• Hibernating wild bears with anuria are protected against many of the complications observed 
in humans with CKD, such as muscle wasting, osteoporosis and azotaemia; future studies should 
investigate the mechanisms behind these protective effects.  
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Box 1: The cytoprotective effects of the transcription factor NRF2  
The transcription factor nuclear factor erythroid 2-related factor 2 (NRF2) upregulates 
the expression of cell-detoxifying enzymes in response to oxidative stress. Activators of NRF2 
induce structural changes in Kelch-like ECH-associated protein 1 (KEAP1), which allows nuclear 
translocation of NRF2. In the nucleus, NRF2 initiates the transcription of >250 target genes, 
such as haemoxygenase, catalase and glucose-6-phosphate 1-dehydrogenase, which are 
important for antioxidant defences, through binding to antioxidant response elements (see the 
figure).  
Nrf2-knockout mice have increased susceptibility to kidney damage. As impaired NRF2 
activation is observed in renal fibrosis, focal segmental glomerulosclerosis and hypertensive 
kidney disease, NRF2-targeting therapies should be of interest for the study of CKD progression. 
Patients on haemodialysis have downregulated levels of NRF2 coupled with an upregulation of 
nuclear factor B (NF-B) (280), and display a phenotype characterized by persistent systemic 
inflammation (81) and increased oxidative stress (281). Given the potential contribution of a 
repressed NRF2 system in premature ageing, both synthetic compounds, such as bardoxolone 
methyl (282) and natural nutrigenomic compounds , such as sulforaphane (283), pomegranate 
polyphenols (284), curcumin (285), ethanol extract of Alisma orientale tubers (286) and 
cinnamon polyphenols (287) that restore NRF2 expression could slow progression and ageing-
related CKD (288). Indeed, since sulforaphane (found in broccoli) inhibits restenosis by 
suppressing inflammation and proliferation of VSMCs in a carotid injury model (289) it has been 
suggested that dietary activators of NRF2 inhibit atherogenesis (290). Moreover, sulforaphane 
suppresses NRF2-mediated hepatic glucose production and attenuates exaggerated glucose 
intolerance by an order of magnitude similar to that of metformin in patients with type 2 
diabetes mellitus (T2DM) (283). However, forced overexpression of NRF2 might not always be 
enough to restore adaptive responses (291). For example, the potent NRF2 agonist bardoxolone 
methyl increases the risk of heart failure compared with placebo in a clinical trial with patients 
with T2DM and stage 4 CKD (292), which highlights potential limitations of manipulating 
transcription factors. Although activation of NRF2 leads to improved anti-oxidant defences, 
whether this effect is independent of any influence on mitochondrial dynamics remains to be 
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determined. Sulforaphane, for example, modulates the KEAP1–NRF2 antioxidant element 
response signalling pathway, yet is a NRF2-independent inhibitor of mitochondrial fission (293). 
Whether such an effect for bardoxolone contributed to its failure due to excess mortality (292) 
remains to be proven. In future clinical trials of bardoxolone methyl, attention should be given 
to the dose-dependent effects on CKD progression (294). Whereas too little NRF2 activity can 
result in loss of cytoprotection, diminshed β-oxidation of fatty acids and lower antioxidant 
capacity, too much NRF2 activity may perturb the homeostatic balance and promote 
overproduction of reduced glutathione and nicotinamide adenine dinucleotide phosphate 
(NADPH) (295) .  
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Figure 1: Novel insights to treatment strategies of CKD from studies of wild animals. Several 
species in the animal kingdom have developed protective mechanisms against environmental 
stresses, and studying these mechanisms can provide insights into novel approaches to chronic 
kidney disease (CKD). For example, despite a long period of immobilization during hibernation, 
bears do not develop azotaemia, osteoporosis, thrombosis, atherosclerosis and muscle wasting, 
which could provide clues for better organ preservation. Naked mole rats (Heterocephalus 
glaber) are protected from oxidative stress, which could help to develop strategies to prevent 
or slow down premature ageing. As weddel seals (Leptonychotes weddellii) are protected 
against prolonged episodes of kidney ischaemia, they could provide insights to prevent acute 
kidney injury. Vampire bats (Desmodus rotundus) are protected against the consequences of a 
high-protein intake, whereas felids (such as tigers) are particularly susceptible to CKD, most 
likely due to their high intake of red meat.  
Figure 2: Effect of red meat intake on kidney functions. Epidemiological studies suggest that 
red meat (but not other sources of protein) promotes chronic kidney disease (CKD). Several 
factors have been proposed to be implicated in the disease-promoting effects of a diet rich in 
red meat. Besides hyperfiltration due to a high-protein load (causing a haemodynamic insult), 
elevated levels of trimethylamine-N-oxide (TMAO) generated from gut microbiota and the 
metabolism of trimethylamine (TMA) in the liver could contribute to CKD via renal fibrosis and 
indirectly via atherosclerosis. Additional pathophysiological mechanisms linking a high intake of 
red meat to cardiovascular disease, cancer and CKD have been reported. Increased intake of 
salt, phosphate (PO4), saturated fats, acid production, haeme iron, uric acid, nucleic acids and 
N-nitroso compunds with a high consumption of red meat may also contribute to the observed 
associations between increased red meat consumption and CKD. The intestinal microbiome 
represents a new potential therapeutic target for the prevention of CKD and for treatment of 
cardio-metabolic complications in CKD.  
Figure 3: Extreme models of ageing with a marked discrepancy between chronological and 
biological age can be used to learn more about progeric processes in CKD. Children with the 
rare Hutchinson–Gilford progeria syndrome (HGPS) express truncated lamin (progerin) that 
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mediates premature ageing, especially in the cardiovascular system, resulting in premature 
death from stroke or myocardial infarction. On the other hand, naked mole rats undergo 
negligible senescence and can live for >30 years without signs of cardiovascular ageing. 
Integration of data from these two extreme models of ageing can reveal detailed mechanisms 
of the progeric phenotype. A high biological age is characterized by a premature ageing 
phenotype; which includes vascular stiffness, frailty, osteoporosis, sarcopenia, as well as high 
levels of inflammation, carbonylation and oxidative stress. CKD, chronic kidney disease; SASP, 
senescence-associated secretory phenotype. 
 
Figure 4: Strategies to increase life span, protect organs and avoid renal ischaemia–
reperfusion injury. Premature cardiovascular death and vascular progeria are prominent 
features of CKD. Based on insights from long-lived animals and basic research, several 
treatment strategies have been identified that could be tested for their effect on longevity. 
Activation of the cytoprotectant functions of hydrogen sulphide (H2S), via restriction of the 
sulphur-containing amino acid methionine, is of major interest. Other potential treatment 
strategies that activate anti-inflammatory and anti-oxidant pathways include dietary restriction, 
senotherapies, sirtuin (NAD+-dependent protein deacetylases) agonists, 5'-AMP-activated 
protein kinase (AMPK) agonists, mechanistic target of rapamycin (mTOR) agonists, extracellular 
secretory vesicles and H2S-releasing salts. Studies suggest that activation of mTOR and nuclear 
factor (erythroid-derived 2)-like 2 (NRF2) signalling by such therapies may increase longevity, 
aid organ protection and decrease the risk for renal ischaemia and reperfusion injuries. Because 
hibernation shares some features and pathways associated with longevity, it can also be 
speculated that hibernation depends on these pathways. 
 
Figure 5: Nitrogen metabolism in hibernating bears. To conserve mobility and muscle strength, 
hibernating bears minimize muscle protein loss and re-utilize the vast majority of urea 
produced, which is mediated by microbial ureolysis and urea-N resorption. Multiple 
mechanisms are responsible for the reduction in serum urea levels during hibernation. Lower 
urea production during hibernation leads to reduced amino acid degradation. Moreover, urea is 
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reabsorbed from urine via solute and water channels, such as urea transporters and aquaporin 
channels, in a leaky bladder wall. The reabsorbed urea is believed to be recycled back into 
skeletal muscle. Urea is also hydrolyzed by urease-expressing gut bacteria into ammonia, which 
is used by enterocytes to synthetize glutamine for incorporation into proteins. Other factors 
that may prevent muscle loss in hibernating animals include activation of peroxisome 
proliferator-activated γ-receptor coactivator 1α (PGC1), for example by cold environmental 
temperature and the low-energy state, and serum-glucocorticoid kinase 1 (SGK1). Urea levels 
decrease in the autumn when food is still available, and the metabolic changes that determine 
urea metabolism may occur already before the bear enter hibernation. Since sirtuin (SIRT) 
stimulators, such as polyphenols in berries and plants, stimulate carbamoyl phosphate 
synthetase 1 (CPS1), which is the first and rate-limiting step of the urea cycle, this may decrease 
urea generation and prepare the animal for low urine output during hibernation. 
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Table 1: Selected animal models that are useful for comparative physiology studies.  
Species/family Area Mechanisms and possibilities 
   
Naked mole rat 
(Heterocephalus glaber) 
Gerontology 
Nephrology 
Oncology 
Cardiology 
These animals have developed protective 
mechanisms against cancer, hypoxia, 
cardiovascular ageing and oxidative stress 
(high NRF2 expression levels).  
Vampire bat (Desmodus 
rotundus) Nephrology 
Blood-ingesting bats have a very high intake 
of proteins, which causes azotaemia (high 
serum urea levels). Studies of vampire bats 
may help to better understand how kidneys 
can be protected against protein overload. 
Ursidae family (bears)  
Nephrology 
Endocrinology 
Cardiology 
Orthopedics 
Transplantology 
Bears do not develop insulin resistance 
during summer despite a 25-50% 
accumulation in body weight (fat mass) from 
spring to autumn. Moreover, despite 
prolonged fasting, anuria and immobilisation 
during hibernation, bears are protected 
from muscle wasting, pressure ulcers, 
thrombotic complications and osteoporosis. 
Studies of hibernating bears may help 
identify novel strategies to handle and 
prevent these complications as well as 
better ways of organ preservation. 
Felidae family (cats) Nephrology 
Domestic and captive felids have a high 
incidence of CKD. As members of this family 
are obligate carnivores, studies of felids may 
provide information on links between red 
meat consumption, gut microbiota and renal 
disease. 
Phocidae family (seals)  Nephrology 
Seals can survive prolonged asphyxia during 
underwater dives up to 120 min. Although 
their kidneys are subjected to prolonged 
vasoconstriction during diving, seals do not 
develop acute kidney injury. 
Elephantidae family 
(elephants) Oncology 
The risk of elephants developing cancer is 
only 5% compared with 25% in humans, 
although they have 100x as many cells. This 
protection may be due to the 20 copies of 
the tumour suppressor gene TP53, whereas 
humans only have 1 copy (2 alleles).  
Chimpanzee (Pan 
troglodytes) Pharmacology 
Chimpanzees have developed ways to 
protect themselves against pathogens by 
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self-medicating with various plant leaves. 
Since one of these plants (thiarubine A) 
contains an antibiotic, systematic studies of 
these plants may help us find novel 
antibiotics. 
Trochilidae  
family 
(hummingbirds) Diabetology 
Hummingbirds can switch their energy 
source from glucose to fructose, which 
maximizes fat storage and optimizes energy 
use to power their high-energy lifestyle 
(their heart rate can reach >1200 
beats/min). Despite hyperglycaemia, they 
do not seem to develop diabetic 
complications. 
Testudine family (turtles) Neurology 
Turtles have a high anoxic tolerance and 
studies of these animals may help scientists 
to develop novel therapeutic strategies for 
cerebral ischaemia. 
Wood frog (Lithobates 
sylvaticus) 
 Physiology 
Frozen wood frogs have 10–13-fold higher 
glucose concentrations in muscle and heart 
than other frog species that have been 
frozen in the laboratory and have natural 
antifreeze glycolipids in muscle and internal 
organs to protect their cells. These 
mechanisms help them to survive over-
wintering in average temperatures of -6.3°C 
(minimum -18.1°C) between October and 
May in the interior of Alaska. Studying wood 
frogs can help to understand limits to 
freezing tolerance.  
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Glossary terms 
 
Uraemic phenotype 
This phenotype includes several physical characteristics, such as vascular stiffness, sarcopenia, 
frailty, osteoporosis and left ventricular hypertrophy.  
 
Chronic tubulointerstitial fibrosis 
Diseases that affect the physiology of non-glomerular structures (tubules and/or the 
interstitium) in the kidney.  
 
Glomerular haemodynamics  
Regulation of efferent and afferent glomerular arteriolar resistance required to maintain a 
stable GFR. 
 
Urinary specific gravity 
A urine specific gravity test compares the density of urine to that of water.  
 
N-nitroso compounds  
Compounds found in processed meat and are formed endogenously from the intake of nitrite 
and nitrate. 
 
Telomere attrition 
Telomeres are the protective end caps of chromosomes. Attrition, or shortening, of telomeres 
is a form of tumour supression and may be due to inflammation, oxidative stress as well as 
exposure to infectious agents, resulting in limited stem cell function, regeneration and organ 
maintenance during ageing.  
 
Uraemic milieu  
The toxic internal milieu in patients with uraemia is characterized by accumulation of uraemic 
toxins and waste products that promote inflammation, oxidative stress, carbonylation, 
calcification and endothelial dysfunction. 
 
Senescent cells 
Cellular senescence is an irreversible cell cycle arrest mechanism that acts to protect against 
cancer. Senescent cells also have a role in complex biological processes, such as development, 
tissue repair, and age-related disorders. 
 
Hypercapnia 
Abnormally elevated carbon dioxide (CO2) levels in the blood. 
 
High molecular weight hyaluronan 
A high-molecular-weight polysaccharide found in the extracellular matrix, especially in soft 
connective tissues. 
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Antagonistic pleiotropy 
Scenarios in which one gene contributes to multiple traits, whereby at least one of these traits 
is beneficial and at least one is detrimental to the organism's health.  
 
PO4 appetite  
A well-documented behaviour in animals that is induced by phosphate deficiency, which is 
especially common amongst herbivores.  
 
Protein–energy wasting  
A process characterized by a decline in body protein mass and energy reserves, including 
muscle and fat wasting and loss of visceral proteins. Protein energy wasting is often associated 
with inflammation and is a strong predictor of mortality. 
 
Caloric restriction 
A reduction in calorie intake without incurring malnutrition or a reduction in essential nutrients. 
In a variety of species, such yeast, fish, rodents and dogs, calorie restriction has been shown to 
slow the biological ageing process. 
 
Sirtuin  
Sirtuins (or NAD+-dependent histone deacetylases) are a class of proteins that possess 
deacylase activity and regulate important biological pathways and cellular processes, including 
ageing, inflammation, transcription and apoptosis. Sirtuin agonists include pterostilbene and 
resveratrol.  
 
Transsulfuration pathway 
A metabolic pathway that involves the interconversion of homocysteine and cysteine via the 
intermediate cystathionine.  
 
Protein sulfhydration 
A post-translational modification that increases the catalytic activity of proteins. Physiological 
actions of sulfhydration include the regulation of endoplasmic reticulum stress signalling, 
inflammation and vascular tension. 
 
One-carbon methyl donor units  
DNA methylation influences the expression of some genes and depends upon the availability of 
methyl groups. Dietary methyl groups are derived from food sources that contain methionine, 
one-carbon units, choline or betaine (a choline metabolite).  
 
Torpor  
A state of reduced body temperature and metabolic rate in animals that enables them to 
survive periods of reduced food availability.  
 
Circadian clock  
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The circadian clock regulates the internal and external activities of organisms, such as sleep and 
changes in metabolism, based on the day–night cycle.  
 
Chronotherapy 
The science of timing drugs according to the circadian clock. This approach is used in various 
clinical conditions, such as cancer, hypertension, seasonal affective disorder and bipolar 
disorder. 
 
Renal lobulation  
Carnivores and most small mammals have smooth-surfaced and uni-pyramidal kidneys, 
whereas primates and Suidae (hogs and pigs) have a smooth-surfaced and multi-pyramidal 
kidney system. Large terrestrial mammals have multi-lobulated and multi-pyramidal kidneys to 
keep the proximal convoluted tubules short. Most marine mammals and bears have each lobe 
separated into renules (reniculated kidney system).  
 
Therapeutic hypothermia (also known as targeted temperature management).  
The induction of mild hypothermia (32–35°C) after cardiac arrest for neuroprotection. 
 
Sedentary behaviour 
A type of behaviour that is characterized by an energy expenditure ≤1.5 metabolic equivalents 
while in a lying, reclining or sitting posture. Typical sedentary behaviours include watching TV, 
computer work, driving and reading. 
 
Denervation 
Loss of nerve supply to a part of the body, which can be due to multiple causes, such as surgery, 
physical injury, chemical toxicity or diseases.  
 
Disuse atrophy 
A type of muscle atrophy that occurs when a muscle is less active than usual. Disuse atrophy is 
a common feature in chronic debilitating diseases and immobility.  
 
Mechanical unloading 
A mechanical manoeuvre or therapy that decreases tissue growth and regeneration. Whereas 
mechanical loading of mammalian tissues is a potent promoter of tissue growth and 
regeneration, mechanical unloading in microgravity causes reduced tissue regeneration via 
stem cell tissue progenitors. 
 
Eucalcaemia  
The maintenance of normal and constant serum calcium levels.  
 
Blueberries 
Blueberries comprise all blue-coloured berries of the vaccinum genus, of which the most 
common is bilberries. Blueberries have a low glycaemic index and are a rich source of fibers, 
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vitamin K, manganese, >15 different anthocyanins (especially delphinidin and malvidin), 
quercetin, myricetin and resveratrol.  
 
Anthocyanins  
Anthocyanins (>600 molecular structures) belong to a class of molecules called flavonoids that 
are universal plant colorants responsible for the red, purple and blue colours in many fruits, 
berries, vegetables and flowers. Due to their contribution in multiple physiological activities, 
the consumption of these molecules is believed to have a substantial role in preventing 
lifestyle-related diseases. 
 
Senolytic effects  
Senolytic compounds selectively induce the death of senescent cells.  
 
Nutrigenomic compounds 
Bioactive nutrients that have an effect on or interact with the genome. Nutrigenomics also 
encompasses the effect of genetic variations on the absorption, metabolism, elimination or 
biological effects of various nutrients.  
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Some animals have developed mechanisms to protect them from environmental stresses, 
whereas others remain susceptible. Here, Stenvinkel et al. discuss how a better understanding 
of susceptibility and protective mechanisms could provide insights to novel strategies for the 
prevention and treatment of several human diseases, such as chronic kidney disease and 
ageing-associated complications.  
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